Article Information
History
- March 17, 2017.
Article Versions
- Version 1 (January 18, 2017 - 21:05).
- You are currently viewing Version 2 of this article (March 17, 2017 - 12:05).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Chiara Mariottini1,2,
- Leonardo Munari1,
- Ellen Gunzel1,2,
- Joseph M. Seco1,
- Nikos Tzavaras1,
- Jens Hansen1,2,
- Sarah A. Stern4,5,
- Virginia Gao4,5,
- Georgia E. Hodes3,
- Scott J. Russo3,
- Vicki Huff6,
- Marc Birtwistle1,2,
- Cristina M. Alberini4,
- Robert D. Blitzer1,7 and
- Ravi Iyengar*,1,2
- 1Department of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 2Systems Biology Center New York Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 3Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 4Center for Neural Science, New York University, New York, NY, USA
- 5Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 6Department of Genetics, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
- 7Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- ↵*Correspondence and requests to: Dr. Ravi Iyengar, Dept. of Pharmacology and Systems Therapeutics, Box 1215, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, New York, NY,10029. ravi.iyengar{at}mssm.edu, Phone 212-659-1707